Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

Background: Several placebo controlled studies have demonstrated the efficacy of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of this new biological compound has been less studied. Aim: To assess the use of infliximab in IBD in a population based cohort, with special emp...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ljung, T, Karlén, P, Schmidt, D, Hellström, P M, Lapidus, A, Janczewska, I, Sjöqvist, U, Löfberg, R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Copyright 2004 by Gut 2004
Konular:
Inflammatory Bowel Disease
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774085/
https://ncbi.nlm.nih.gov/pubmed/15138212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.018515
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller